Is there any precedent for meeting with the FDA to discuss phase 3 tests to potentially make them more efficient? What are we expecting in this meeting?
Neuren Media and Analyst Coverage, page-1351
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.17 |
Change
0.060(0.46%) |
Mkt cap ! $1.706B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.44 | $13.07 | $3.891M | 292.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1379 | $13.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.17 | 223 | 11 |
View Market Depth
| Last trade - 15.44pm 18/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |